SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-033674
Filing Date
2012-06-13
Accepted
2012-06-13 15:50:56
Documents
2
Period of Report
2012-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1634
2 POA DOCUMENT poa.txt EX-24.3_428689 3547
  Complete submission text file 0001209191-12-033674.txt   6444
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Horton Kenneth L (Reporting) CIK: 0001552047 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 12905164